missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ METAP2 Recombinant Rabbit Monoclonal Antibody (23GB2565), Invitrogen™
Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA553517
This item is not returnable.
View return policy
Description
The ADP-ribosylation factor (Arf) family are highly conserved members of the Ras superfamily of regulatory GTP-binding proteins. Arf proteins participate in routing of intracellular proteins to and within the Golgi complex. Cellular functions include maintenance of organelle integrity, coat protein assembly, as an activator of phospholipase D. The Arf family is divided functionally into the Arf and the Arf-like (Arl) proteins. The ARF proteins are categorized as class I (ARF1, ARF2 and ARF3), class II (ARF4 and ARF5) and class III (ARF6) and members of each class share a common gene organization.
Specifications
| METAP2 | |
| Recombinant Monoclonal | |
| 0.4 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O08663, P38062, P50579 | |
| METAP2 | |
| A synthesized peptide derived from human Methionine Aminopeptidase 2 (420-478AA). | |
| 20 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
| Flow Cytometry, Western Blot, Immunocytochemistry | |
| 23GB2565 | |
| Unconjugated | |
| METAP2 | |
| 4930584B20Rik; A930035J23Rik; AI047573; AL024412; Amp2; AU014659; eIF-2-associated p67; eIF-2-associated p67 homolog; initiation factor 2 associated 67 kDa protein; initiation factor 2-associated 67 kDa glycoprotein; initiation factor 2-associated protein (p67); MAP 2; MAP2; metAP 2; Metap2; Methionine aminopeptidase 2; methionyl aminopeptidase 2; Mnpep; p67; p67eIF2; Peptidase M; peptidase M 2; similar to methionyl aminopeptidase 2; testicular tissue protein Li 17 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 10988, 56307, 64370 | |
| -20°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction